Animalcare Group PLC Appointment of Non-Executive Director (3425B)

TIDMANCR

RNS Number : 3425B

Animalcare Group PLC

10 February 2022

ANIMALCARE GROUP PLC

(the " Company " or the "Group")

Appointment of Non-Executive Director

10 February 2022. Animalcare Group plc (AIM: ANCR), the international animal health business, today announces the appointment of Dr Douglas Hutchens to its Board of Directors as an Independent Non-Executive Director with immediate effect .

Douglas Hutchens has held several senior positions in research and development (R&D) and regulatory affairs at leading global animal health companies. As part of the executive team at Bayer Animal Health, he was an Executive Vice President and Chief Veterinary Officer where he led both drug discovery and product development on a global basis. More recently, he has held positions on several R&D advisory boards.

Before joining the animal health pharmaceutical industry, Douglas was an Assistant Professor at the University of Illinois College of Veterinary Medicine. There, he conducted studies for most of the major animal health companies and participated in the development of multiple new products for companion and production animals. Early in his career he was a practicing veterinarian. Douglas holds a Doctor of Veterinary Medicine degree and a PhD in pathobiology with an emphasis in immuno-parasitology from the University of Illinois.

Jan Boone, Chairman of Animalcare Group plc, said: " We are delighted to welcome Douglas to the Animalcare Group Board. Douglas brings a wealth of expertise in veterinary medicine and R&D from leadership roles at some of the world's biggest animal health companies . His knowledge and extensive network will prove invaluable as we pursue our long-term growth strategy ."

Additional Information

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Douglas Eugene Hutchens, aged 58:

 
 Current Directorships   Previous Directorships 
 None                    Bayer Animal Health GmbH 
 
 
 
 

As of the date of this announcement, Dr Hutchens holds no ordinary shares in the capital of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

Enquiries

 
 Animalcare Group plc                [phone] 
  Jenny Winter, Chief Executive 
  Officer 
  Chris Brewster, Chief Financial     [e-mail] 
  Officer 
  Media/investor relations 
 Stifel Nicolaus Europe Limited 
  (Nominated Adviser & Joint 
  Broker) 
  Ben Maddison 
  Fred Walsh 
  Nicholas Harland 
  Nick Adams                         [phone] 
 Panmure Gordon 
  (Joint Broker) 
  Corporate Finance 
  Freddy Crossley/Emma Earl 
  Corporate Broking 
  Rupert Dearden                     [phone] 
 

About Animalcare

Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

For more information about Animalcare, please visit www.animalcaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOADZGMZDGDGZZM

(END) Dow Jones Newswires

February 10, 2022 09:46 ET (14:46 GMT)